Analyst Ratings For Solid Biosciences (NASDAQ:SLDB)
Today, Chardan Capital initiated coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy with a price target of $40.00.
Some recent analyst ratings include
- 2/21/2018-Chardan Capital initiated coverage with a Buy rating.
- 2/20/2018-Nomura initiated coverage with a Buy rating.
- 2/20/2018-Instinet initiated coverage with a Buy rating.
- 2/20/2018-Leerink Swann initiated coverage with a Outperform rating.
- 2/20/2018-JPMorgan Chase & Co. initiated coverage with a Neutral rating.
- 2/20/2018-Goldman Sachs Group initiated coverage with a Neutral rating.
Recent Trading Activity for Solid Biosciences (NASDAQ:SLDB)
Shares of Solid Biosciences closed the previous trading session at 24.80 up +0.94 3.94% with 24.04159927368164 shares trading hands.